AR of T or DHT. However, ADT is not curative and CaP recurs as lethal castration-recurrent/resistant CaP (CRPC). One mechanism that contributes to resistance of CaP to ADT is intracrine metabolism, the conversion of weak adrenal androgens, dehydroepiandrosterone (DHEA) or androstenedione (ASD) to T or DHT.
1,2 Anti-androgens, such as enzalutamide, or anti-androgen metabolism drugs, such as the CYP17 inhibitor, abiraterone acetate extend patient survival by only several months. 3, 4 Identification, development, and characterization of new therapeutic agents to inhibit CaP growth or recurrence using various forms of ADT rely on using combinations of in vitro and in vivo models.
In vitro models include human CaP cell lines, such as the androgensensitive LAPC-4 5 and LNCaP, and the androgen-independent LNCaP derivative, LNCaP-C4-2 (C4-2). 6 Different cell lines require different culture conditions. However, one common component used for cell culture maintenance is fetal bovine serum (FBS). Culture media typically contain 10% FBS, which yields T concentrations 0.03-0.097 nM T, 7 but serum composition varies from batch-to-batch. 8 One factor that contributes to FBS variation is that commercially available FBS compositions vary due to differences in genetic background and husbandry of cattle. Charcoal or charcoal and dextran are used to remove androgens and estrogens from FBS to produce charcoalstripped FBS (CS-FBS), which is added commonly to growth media to produce androgen-free media. However, the stripping process removes molecules necessary for cell growth and metabolism. The stripping process is inconsistent and CS-FBS composition varies from batch-to-batch. 9 One alternative to using CS-FBS containing media for androgen deprivation is androgen-free defined media, such as serumfree media (SFM). The goal of these in vitro studies was to compare
CaP cell growth and androgen metabolism in control media versus media altered to achieve androgen deprivation.
| MATERIALS AND METHODS

| Cell culture and reagents
Human CaP lines, LAPC-4, 10 LNCaP-RPCI (LNCaP), 5, 11 PC-3 (acquired from ATCC), and C4-2 6, 12 were cultured in RPMI 1640 (Corning, Corning, NY). VCaP (acquired from ATCC) was cultured in Dulbecco's Modified Eagle Medium (DMEM, Corning). RPMI and DMEM were supplemented with 10% FBS (Corning) and 2 mM glutamine (Corning).
CWR-R1 13 was cultured in Richter's Improved media (Corning)
supplemented with 2% FBS, 10 mM nicotinamide, 20 ng/mL epidermal growth factor, 5 μg/mL Insulin/transferrin/selenium (ITS) and 5 μg/mL linoleic acid. Media that contained FBS were considered control media (CM). SFM (Serum Free Complete Media, Corning) contains bovine serum albumin (1 g/L) and L-glutamine and other proprietary additives.
Charcoal-stripped media (CSM) were identical to CM except that FBS was substituted with CS-FBS. CS-FBS was not purchased due to concerns for batch-to-batch variability. Instead, CS-FBS was generated in our laboratory from FBS that was incubated twice for 1 h with activated charcoal (Avantor, Center Valley, PA) and dextran (Amresco, Solon, OH) and sterilized using 0.2 μm filter (ThermoFisher Scientific, Waltham, MA). Liquid Chromatography-tandem mass spectrometry (LC-MS/MS) analysis confirmed CS-FBS androgen levels were below the limit of quantitation (BLQ). Cells were harvested using trypsin 0.05% (Corning). Dulbecco's phosphate buffered saline (PBS; Corning)
was used for all cell washes.
All cell lines were authenticated using genomic profiling in the The modified assay used aqueous-based spiked calibration standards to document calibration ranges and confirm quality control (Supplemental Table S1 ). Androgen or dutasteride quality control samples were prepared in charcoal-stripped human postmenopausal female plasma (Bioreclamation, LLC, Westbury, NY). Calibration ranges, QC concentrations and overall performance of the assay were listed in Supplemental Table S1 . Cell pellet samples were resuspended to total volume 1 mL in water and vortexed or sonicated to obtain a homogeneous suspension. Analytes were detected using multiple reaction monitoring (MRM) in positive ion mode controlled by AB SCIEX Analyst® software, version 1.6.2. Mass spectrometer conditions were ion spray voltage 5250 volts, turbo gas temperature 700°C, gas 1 = 65, gas 2 = 60, curtain gas = 20, collision-associated dissociation (CAD) gas medium and unit mass resolution for Q1 and Q3. Nitrogen was used for all gases and voltages for maximum parent/fragment ion pair intensities were optimized using direct infusion and flow injection analysis. Calibration curves were generated using analyte/IS area response ratios versus nominal concentrations (ng/mL) and weighted linear regressions with weighting factor 1/concentration 2 . The IS used for T, ASD and DHEA was d 3 -T and d 3 -DHT was used for DHT and AND. The IS used for dutasteride was 13 C 6 -dutasteride. Back-calculated concentrations were generated using the formula x = (y−b)/m, where x is the backcalculated concentration, y is the analyte/IS peak area ratio, b is the yintercept, and m is the slope. Calibrator and quality control acceptance criteria required all acceptable concentrations to have accuracy deviations ≤15% from the nominal concentration, with relative standard deviations (% RSD) ≤15%, except at the lower limit of quantitation (LLOQ), which was allowed ≤20% deviation for both parameters. Values that were BLQ were treated as 0.0 ng/mL.
| Cell viability
Analyte concentrations were represented as pmoles/mg protein.
Cell lysates measured using LC-MS/MS (ng/mL) were multiplied by the total volume of lysate (1 mL 
| Western blotting
Western blots analyses were performed on all three biological replicates generated for LC-MS/MS analyses. Cells removed from −80°C storage were re-suspended in ubiquitin extraction lysis buffer 3 | RESULTS
| CaP cell growth persisted when cultured in SFM or CSM media for 6 days
Six commonly used CaP cell lines were cultured in CM or were androgen deprived using SFM or CSM for 6 days and cell growth was measured.
The 6 day time point was chosen because previous reports showed CaP cell growth slows or CaP cells undergo apoptosis 6 days after androgen deprivation. 15, 16 All CaP cell lines grew (all P-values <0.05 that compared Day 6 to Day 0) after 6 days of culture in CM, SFM, or CSM ( Figure 1C ;
Supplemental Figures S1A and S1B and Supplemental 
| T stimulated LNCaP and VCaP growth in SFM or CSM
Since LNCaP and VCaP cell growth differed in CM, SFM, or CSM, media were supplemented with T to determine if the differences were Table S3 ).
| Bicalutamide treatment impaired T-stimulated CaP cell growth in SFM or CSM
MTT experiments were performed using LNCaP, LAPC-4, VCaP, and Table S5 ). The data suggested LAPC-4 cells metabolized T to ASD when T or DHT levels were sufficient to activate AR. Cell growth was measured on days 0 and 6 using MTT assay (OD590). Cell growth was expressed as percent growth. Data were presented as mean +/− SEM. P-values for statistical comparisons among CaP cells cultured in CM, SFM, or CSM were listed in Supplemental Table S2 . P-values for statistical comparisons between Day 0 OD590 and Day 6 OD590 were listed in Supplemental Table S2 FIGURE 2 SFM or CSM supplemented with T stimulated LNCaP and VCaP cell growth. LNCaP (A and B), LAPC-4 (C and D), VCaP (E and F) or C4-2 (H and I) cells were cultured in CM, SFM, or CSM alone or CM, SFM, or CSM with 1 nM T. Cell growth was measured on days 0 and 6 using MTT assay (OD590). Data were presented as mean +/− SEM. P-values for statistical comparisons of cell growth between Day 0 and Day 6 were listed in Supplemental Table S3 . Comparisons among CaP cells cultured in CM, SFM, or CSM alone or CM with T, SFM with T, or CSM with T were listed in Supplemental Table S3 FIANDALO ET AL. Supplemental Table S4 . Cell growth comparisons among T and B and SFM versus CSM treatments were listed in Supplemental Table S4 FIGURE 4 Androgen levels were similar among LAPC-4 cells cultured 6 days in SFM or CSM. Androgen metabolism pathways for DHT synthesis (A). LAPC-4 cells were analyzed using LC-MS/MS to measure T (B), DHT (C), and ASD (D) levels after LAPC-4 cells were cultured for 6 days in CM, SFM, or CSM alone or cultured in CM, SFM, or CSM with 1 nM T. Cell pellet and media androgen levels were combined. Cell pellet and media androgen levels were shown in Supplemental Figure S1 . Data were presented as mean pmoles/mg protein +/− SEM. Pvalues for statistical comparisons among LAPC-4 cells treated with or without T were listed in Supplemental Table S5 FIGURE 5 Metabolism of T to DHT was impaired in LAPC-4 cultured with dutasteride. LAPC-4 cells were analyzed using LC-MS/MS to measure T (A), DHT (B). ASD (C), and dutasteride (dut; panel D) levels after LAPC-4 cells were cultured for 24 h in CM, SFM, or CSM alone or cultured in CM, SFM, or CSM with 1 nM T or CM, SFM, or CSM with 1 μM Dut or CM, SFM, or CSM with 1 nM T and 1 μM Dut. Cell pellet and media androgen levels were combined. AR protein expression was measured using western blot and quantitated using densitometry (E). Cell pellet and media androgen levels were shown in Supplemental Figure S2 . Data were presented as mean pmoles/mg protein +/− SEM. Pvalues for statistical comparisons among LAPC-4 cells treated with T, dut, or T and dut combined were listed in Supplemental Table S6 were measurable when LAPC-4 cells were cultured with CM, SFM, or CSM supplemented with T. LAPC-4 ASD levels were higher (all P-values <0.05; Supplemental Table S6) Figure 5C and Supplemental Table S6 ). Dutasteride levels were similar among all LAPC-4 cells treated with dutasteride alone or T and dutasteride ( Figure 5D and Supplemental Table S6 ).
Quantitative 
